Privately-held Flare Therapeutics, a US biotech targeting transcription factors to discover precision medicines for oncology ...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

Flare Therapeutics has entered into a strategic discovery collaboration with Roche. The partnership will leverage Flare Therapeutics' ...

Combining Flare's advanced proteomic and mass spectrometry platform ? powered by its proprietary library of electrophilic compounds ? to discover small molecule drugs targeting transcription factors ...